Lymph node dissection in resectable advanced gastric cancer

Digestive Surgery

Volumn 30, Issue 2, 2013, Pages 96-103

  De Steur, Wobbe O ^a   Dikken, Johan L ^a,b   Hartgrink, Henk H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Lymph node dissection; Stomach neoplasms; Surgery

Indexed keywords

CANCER STAGING; EVIDENCE BASED MEDICINE; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; METHODOLOGY; MORTALITY; PANCREAS RESECTION; PATHOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNET RING CARCINOMA; SPLENECTOMY; STOMACH TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

CARCINOMA, SIGNET RING CELL; EVIDENCE-BASED MEDICINE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; PANCREATECTOMY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84880524825     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000350873     Document Type: Review

References (40)

1. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancerdisparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
2. Yamaoka Y, Kato M, Asaka M: Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008; 47: 1077-1083.
3. Hamashima C, Shibuya D, Yamazaki H, et al: The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259-267.
4. Hundahl A, Phillips JL, Menck HR, et al: The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal, and the 'different disease' hypothesis. Cancer 2000; 88: 921-932.
5. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
6. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
7. Okines A, Verheij M, Allum W, Cunningham D, Cervantes A, ESMO Guidelines Working Group: Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(suppl 5):v50-v54.
8. NCCN: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Gastric Cancer, Version 2, 2011. http://www.nccn.org.
9. Viste A, Haugstvedt T, Eide GE, Soreide O: Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988; 207: 7-12.
10. Bottcher K, Siewert JR, Roder JD, Busch R, Hermanek P, Meyer HJ: Risiko der chirurgischen Therapie des Magencarcinoms in Deutschland: Ergebnisse der Deutschen Magencarcinom-Studie 1992. Chirurg 1994; 65: 298-306.
11. Gouzi JL, Huguier M, Fagniez PL, et al: Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989; 209: 162-166.
12. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L: Subtotal versus total gastrectomy for gastric cancer: five year survival rates in a multicenter randomized Italian trial. Gastrointestinal Tumor Study Group. Ann Surg 1999; 230: 170-178.
13. Bonenkamp JJ, van de Velde CJ, Songun I, et al: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748.
14. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-1530.
15. Sasako M: Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 1997; 84: 1567-1571.
16. Songun I, Bonenkamp JJ, Hermans J, van Krieken JH, van de Velde CJ: Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32: 433-437.
17. Kijitani T: Japanese Research Society for the Study of Gastric Cancer. The general rules for gastric cancer study and pathology. Jap J Surg 1981; 11: 127-145.
18. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11: 418-425.
19. Dent DM, Madden MV, Price SK: Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988; 75: 110-112.
20. Robertson CS, Chung SC, Woods SD, et al: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220: 176-182.
21. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Dutch Gastric Cancer trial group: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340: 908-914.
22. Hartgrink HH, van de Velde CJ, Putter H, et al: Extended lymph node dissection for gastric cancer: who may benefit' Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol 2004; 22: 2069-2077.
23. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ: Gastric cancer -seminar. Lancet 2009; 374: 477-490.
24. Songun I, Putter H, Meershoek-Klein Kranenbarg E, Sasako M, van de Velde CJ: Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-449.
25. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004; 4:CD001964.
26. Degiuli M, Sasako M, Ponti A, Italian Gastric Cancer Study Group: Br J Surg; 97: 643-649.
27. Wu CW, Hsiung CA, Lo SS, et al: Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 2006; 7: 309-315.
28. Sasako M, Sano T, Yamamoto S, et al: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-462.
29. Kampschoer GH, Maruyama K, van de Velde CJ, Sasako M, Kinoshita T, Okabayashi K: Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 1989; 76: 905-908.
30. Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink HH, van de Velde CJ: Low Maruyama index surgery for gastric cancer: blinded re-analysis of the Dutch D1-D2 trial. World J Surg 2005; 29: 1576-1584.
31. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T, Southwest Oncology Group and the Gastric Intergroup: Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002; 9: 278-286.
32. Furakawa H, Hiratsuka M, Ishikawa O, et al: Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas preserving method. Ann Surg 2000; 7: 669-673.
33. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F: A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002; 131: 401-407.
34. Yu W, Choi GS, Chung HY: Randomised clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006; 93: 559-563.
35. Brar SS, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N: A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer. Gastric Cancer 2012; 15(suppl 1):S89-S99.
36. Sano T, Yamamoto S, Sasako M: Randomised controlled trial to evaluate splenectomy in total gastrectomy fgor gastric adenocarcinoma: Japan Clinical Oncology Group Study JCOG 0110-MF. Jpn J Clin Oncol 2002; 32: 363-364.
37. Krijnen P, den Dulk M, Meershoek-Klein Kranenbarg E, Jansen-Lansheer ML, van de Velde CJ: Improved survival after resectable non-cardia gastric cancer in the Netherlands: the importance of surgical training and quality control. Eur J Surg Oncol 2009; 35: 715-720.
38. Birkmeyer JD, Siewers AE, Finlayson EV, et al: Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137.
39. Jensen LS, Nielsen H, Mortensen PB, Pilegaard HK, Johnsen SP: Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol 2010; 36:S50-S54.
40. Birgisson H, Talback M, Gunnarson U, Pahlman L, Glimelius B: Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845-853.